AI-generated summary
The authors report a randomized controlled trial of 32 breast cancer patients who received anthracycline and taxane chemotherapy, comparing photobiomodulation sessions with no intervention. They report that hair regrowth scored by blinded researchers was higher at one month in the photobiomodulation group, and that global health scores were higher at all time points. The authors describe these findings as suggesting faster hair regrowth and improved quality of life.
- Participants
- 32
- Who or what was studied
- Breast cancer patients who underwent anthracycline and taxane-containing chemotherapy at Jessa Hospital, Hasselt, Belgium
- Limits stated in the abstract
- The abstract reports a small sample of 32 patients and does not state wavelengths or the rating scale's validation, so the conclusions rest on a limited trial.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Control group, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.